Fly News Breaks for May 9, 2018
AMED
May 9, 2018 | 07:48 EDT
Oppenheimer analyst Michael Wiederhorn raised his price target for Amedisys to $77 from $68 after the company reported a large Q1 beat. The analyst reiterates an Outperform rating on the shares.
News For AMED From the Last 2 Days